Henderson Group »

Taysha Gene Therapies shares owned by Henderson Group

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $308k 69k 4.47

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Group
State Street Corporation
Vanguard Capital Management
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays

View all funds holding Taysha Gene Therapies